-
-
-
-
-
-
-
Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
-
-
-
-
-
-
-
Zymeworks (ZYME) Reiterated at Market Outperform by Citizens After Q1 Results
-
-
-
-
-
-
-
Zymeworks (ZYME) PT Raised to $47 at Stifel
-
-
-
-
-
-
-
Zymeworks (ZYME) Reiterated at Market Outperform by Citizens: Shares Attractive
-
-
-
-
-
-
-
Zymeworks (ZYME) PT Raised to $40 at Stifel
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
-
-
-
-
-
-
-
Zymeworks gets FDA clearance for liver cancer drug trial
-
458,134 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

